Engineering model-based systems to monitor and steer subclonal dynamics
Engineering model-based systems to monitor and steer subclonal dynamics
批准号:
10633383
负责人:
Noemi Andor
金额:
$23.63万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-05-01 至 2025-04-30
关键词:
AdoptedBackBehaviorBiologicalBiological AssayBiological MarkersBiopsyCancer BiologyCancer cell lineCarrying CapacitiesCell CountCell Culture TechniquesCell LineCell LineageCell divisionCellsClinicalClinical TrialsCollaborationsComplexComputer AnalysisComputer Vision SystemsComputer softwareCrystallizationDNADataData CollectionDatabasesDrug ScreeningEarly DiagnosisEngineeringEnvironmentEquipmentEvolutionExhibitsExperimental DesignsFailureFoundationsFutureGenerationsGeneticGenetic TranscriptionGenomeGenomic InstabilityGenotypeGrowthHabitsHarvestHealthHeterogeneityImageIn VitroIndividualJavaLaboratory ResearchLawsLinkMalignant NeoplasmsMathematicsMeasurementMethodologyModelingMonitorMorphologyMycoplasmaNatureNutrientOncologyPathway interactionsPeriodicalsPharmaceutical PreparationsPhasePhenotypePopulationPrimary NeoplasmProteomeProtocols documentationPublishingReagentReproducibilityResearch PersonnelResolutionScientistSilicon DioxideSystemTestingTimecancer heterogeneitycarcinogenesiscontrast imagingcostdriver mutationenvironmental adaptationenvironmental changeexperimental analysisexperimental studyfitnessflexibilitygenetic pedigreehigh throughput screeningin vivolive cell imagingmalignant stomach neoplasmmathematical modelmultiple omicspre-clinicalprototyperesponsesingle cell sequencingsingle-cell RNA sequencingspecific biomarkerssuccesstemporal measurementtranscriptometranscriptome sequencingtumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Primary tumors as well as cancer cell lines have been shown to exhibit extensive genetic and transcriptional
heterogeneity, with multiple subclones co-existing in the same cancer population.1 Even after decades of in-vitro
growth, established cell cultures continue to evolve.2 The heterogeneity of cancer cell lines over space and time
crystallizes into three unmet needs: i) cell culture protocols that offer a high temporal resolution on in-vitro growth
dynamics; ii) close monitoring of the temporal separation between genotypic and phenotypic measurements and
iii) reconciling the cost-prohibitive nature of repeated high-throughput multi-omic measurements with ceaseless
changes in subclonal composition. To fill these needs, we propose to engineer how in-vitro and in-silica experiments
interact into a software solution called CLONEID. An SOL database in the backend, a Java core and an
R user interface will come together to form two modules: One will record the pedigree of lineages grown in a
lab and use computer vision to monitor phenotypic changes, such as variable growth rates. The second module
will link subclonal multi-omics profiles from different high throughput assays to each other and to the phenotypes
from the first module. In aim 1 we will develop the first module and use it to demonstrate feasibility of monitoring
phenotypic transitions of cell lines with CLONE ID at high temporal resolution, without any specialized equipment.
Aim 2 will use this data in conjunction with existing single cell sequencing of the same cell lines to develop and
test the second module and use it to identify subclone-specific biomarkers of growth. Together these aims will
pave the way to more complex mathematical models of carcinogenesis, that do not have to rely on the simplifying
assumption that individual driver mutations have equal fitness effects and that individual subclones have a fixed
growth rate. In the future, the framework developed here will serve as foundation to deploy computer vision for
early detection of morphological changes, including adaptation from in-vivo to in-vitro growth and mycoplasma
contamination.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterizing cytotoxic therapy induced shifts in the cost-to-benefit ratio of high ploidy
-
批准号:10688196
-
项目类别:
-
资助金额:$53.26万
-
财政年份:2022
-
负责人:Noemi Andor
-
依托单位:
Characterizing cytotoxic therapy induced shifts in the cost-to-benefit ratio of high ploidy
-
批准号:10521654
-
项目类别:
-
资助金额:$52.01万
-
财政年份:2022
-
负责人:Noemi Andor
-
依托单位:
A framework to integrate live-cell imaging with single-cell sequencing and learn how cells adapt to new environments
-
批准号:10337650
-
项目类别:
-
资助金额:$9.78万
-
财政年份:2021
-
负责人:Noemi Andor
-
依托单位:
A framework to integrate live-cell imaging with single-cell sequencing and learn how cells adapt to new environments
-
批准号:10530677
-
项目类别:
-
资助金额:$8.17万
-
财政年份:2021
-
负责人:Noemi Andor
-
依托单位:
A clone's genomic stability as biomarker of its DNA-damage resilience
-
批准号:10015210
-
项目类别:
-
资助金额:$24.89万
-
财政年份:2017
-
负责人:Noemi Andor
-
依托单位:
A clone's genomic stability as biomarker of its DNA-damage resilience
-
批准号:10224800
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2017
-
负责人:Noemi Andor
-
依托单位:
国内基金
海外基金
患者依从性与脑卒中后跌倒风险相关性及“Teach-Back ”护理干预效应研究
-
批准号:2026JJ81464
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:叶婷
-
依托单位:
基于Teach-back药学科普模式的慢阻肺患者吸入用药依从性及疗效研究
-
批准号:2024KP61
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:余丹
-
依托单位:
基于Quench-Back保护的超导螺线管磁体失超过程数值模拟研究
-
批准号:51307073
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2013
-
负责人:郭兴龙
-
依托单位: